Coffee Stain (COFFEEB): Five Areas of Focus for Tuesday's Year-End Print
Kristoffer Lindström
May 11, 2026
Tomorrow Coffee Stain prints its first ever full year as a standalone listed company. The headline numbers are not the point. The question we walk in with is whether management is treating Coffee Stain as a portfolio of cash-generating IPs that should be tuned for yield, or as a platform that needs to fund the next thing. Q4 is the cleanest stress test we have so far: no Satisfactory launch tailwind, an inherited live-service (Fellowship), the biggest paid-franchise content drop of the year (Deep Rock Galactic Season 6), the long-awaited Teardown multiplayer release, and a Bloxburg revenue line attached to a Roblox stock down 34% since April 30. Consensus is thin, and tomorrow's reaction will be driven by tone on these five debates more than by the precise number. Share price has been strong since the post-listing forced selling stopped, which may pose an expectations risk if numbers come in below consensus.
Altor, via Snark Bidco, has launched a SEK 24.50 cash offer for Sleep Cycle. The two largest owners (62.9% combined) have already irrevocably accepted, so the deal is, for practical purposes, done. The 47% premium looks generous against Friday's close. It looks a lot less generous against the company Sleep Cycle actually is on the other side of its self-inflicted 2026 investment cycle. Altor is not doing charity.
Better Collective (BETCO): BetMGM Cuts Guidance on Prediction Market Pressure
Kristoffer Lindström
Apr 17, 2026
BetMGM cut 2026 revenue guidance by roughly $200M and named prediction markets as the driver, the first time a US sportsbook has put a number on what was, until now, a theoretical threat. Better Collective sits downstream of these economics, trades at roughly 2x peer multiples, and is funding a EUR 40M buyback partially absorbed by insider sales. The canary is...
Physitrack (PTRK): First US Deal Signals Physitrack's Enterprise Pivot Is Working
Kristoffer Lindström
Mar 30, 2026
Physitrack's first US enterprise deal is immaterial in size, less than 0.3% of Lifecare revenue, but the signal matters more than the dollars. An academic medical center is a credibility-conferring reference account, and this is the third institutional deal in March alone, all enterprise-scale and all with built-in expansion language. The go-to-market is shifting, and the market continues to ignore it...
Physitrack (PTRK): Lands Two Swiss Deals in 17 Days
Kristoffer Lindström
Mar 27, 2026
PTRK announced its second Swiss institutional deal in under three weeks, with bespoke clinical workflow modules that materially raise switching costs. The deals themselves are small, but the pattern of enterprise traction is building. The stock trades at SEK 8.8 versus our SEK 22-25 SOTP, held down by mid-transition optics, indiscriminate SaaS repricing, and Nordic small-cap outflows. The bigger catalyst remains a US win...
Embracer Group (EMBRACB): 30% Drop Reveals an Attractive Implied Coffee Stain Valuation
Kristoffer Lindström
Dec 9, 2025
Embracer’s share price fell 29.8% yesterday to SEK 60 as the stock began trading without the rights to Coffee Stain Group. The decline reflects the arithmetic removal of a subsidiary, not a deterioration in Embracer’s operations.
Physitrack (PTRK): Strategic Restructuring Aligns With Long-Term Value Creation
Kristoffer Lindström
Nov 26, 2025
Lind comments on PTRK's strategic divestment of non-SaaS assets within the Wellness segment. We view the move positively and that it aligns with our long-term investment thesis of PTRK.
Better Collective (BETCO): Unlicensed Exposure on HLTV.org
Kristoffer Lindström
Oct 17, 2025
Field tests confirm that HLTV.org, owned by Better Collective, promotes GG.bet—an unlicensed operator banned by Sweden’s regulator—while remaining accessible from Swedish IPs and accepting SEK deposits. This constitutes illegal marketing under the Swedish Gambling Act, exposing BETCO to compliance scrutiny and reputational damage.
Physitrack (PTRK) - Overhang Lifted, Path to Fair Value Clears
Kristoffer Lindström
Aug 26, 2025
The exit of non-operative co-founder Nathan Skwortsow via an off-market placement on August 22 removes a key overhang that had weighed on Physitrack’s share price. The block was placed at SEK 16.20, with shares rebounding to SEK 18.50 as new institutional investors entered. With fundamentals unchanged and sentiment improving, our conservative SOTP analysis supports an intrinsic value of around SEK 26 per share, implying substantial upside from current levels.
Physitrack (PTRK): What We Hope to See in the Q2 Report
Kristoffer Lindström
Jul 17, 2025
Physitrack (PTRK) is scheduled to release its report for the second quarter of 2025 on July 24. In this note, we outline the key points we will focus on when reviewing the report.
